PMC:7605337 / 41468-43354
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T59 | 758-765 | Body_part | denotes | Alanine | http://purl.org/sig/ont/fma/fma82749 |
T60 | 1472-1479 | Body_part | denotes | Alanine | http://purl.org/sig/ont/fma/fma82749 |
T61 | 1763-1770 | Body_part | denotes | Alanine | http://purl.org/sig/ont/fma/fma82749 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T283 | 32-41 | Disease | denotes | nCOV-2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T284 | 43-47 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T285 | 126-135 | Disease | denotes | nCOV-2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T286 | 190-194 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T287 | 278-287 | Disease | denotes | nCOV-2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T288 | 350-359 | Disease | denotes | nCOV-2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T289 | 565-574 | Disease | denotes | nCOV-2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T290 | 645-649 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T291 | 1045-1054 | Disease | denotes | nCOV-2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T292 | 1089-1093 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T293 | 1161-1170 | Disease | denotes | nCOV-2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T294 | 1557-1561 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T295 | 1748-1752 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T252 | 143-144 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T253 | 167-168 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T254 | 179-180 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | Å |
T255 | 203-204 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T256 | 231-234 | http://purl.obolibrary.org/obo/CLO_0001302 | denotes | 3–4 |
T257 | 235-236 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | Å |
T258 | 344-345 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T259 | 402-405 | http://purl.obolibrary.org/obo/CLO_0001236 | denotes | 2 Å |
T260 | 613-614 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | Å |
T261 | 679-680 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | Å |
T262 | 707-709 | http://purl.obolibrary.org/obo/CLO_0008922 | denotes | S2 |
T263 | 707-709 | http://purl.obolibrary.org/obo/CLO_0050052 | denotes | S2 |
T264 | 835-836 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | Å |
T265 | 894-897 | http://purl.obolibrary.org/obo/CLO_0001236 | denotes | 2 Å |
T266 | 1130-1131 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T267 | 1206-1207 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T268 | 1512-1513 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T269 | 1710-1711 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T270 | 1858-1859 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T128 | 707-709 | Chemical | denotes | S2 | http://purl.obolibrary.org/obo/CHEBI_29387 |
T129 | 758-765 | Chemical | denotes | Alanine | http://purl.obolibrary.org/obo/CHEBI_16449 |
T130 | 1472-1479 | Chemical | denotes | Alanine | http://purl.obolibrary.org/obo/CHEBI_16449 |
T131 | 1763-1770 | Chemical | denotes | Alanine | http://purl.obolibrary.org/obo/CHEBI_16449 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T13 | 944-952 | http://purl.obolibrary.org/obo/GO_0007610 | denotes | behavior |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T283 | 0-259 | Sentence | denotes | Changes in the RBD structure of nCOV-2019, SARS-COV, and mutants from their crystal structure were analyzed by RMSD and RMSF. nCOV-2019 showed a stable structure with a RMSD =1.5 Å, whereas SARS-COV had a larger RMSD value between 3–4 Å during the simulation. |
T284 | 260-334 | Sentence | denotes | Most mutations of nCOV-2019 maintained similar stability to the wild-type. |
T285 | 335-466 | Sentence | denotes | However, a few nCOV-2019 mutations resulted in larger deviations (>2 Å), i.e., Y489A, F456A, Y505A, N487A, K417A, Y473A, and Y449A. |
T286 | 467-711 | Sentence | denotes | We further investigated the structure of the extended loop domain (Figure 1B) and discovered that nCOV-2019 is stable with an RMSD of less than 1 Å, whereas the extended loop in SARS-COV shows an RMSD of about 3 Å during simulation (Figure S2). |
T287 | 712-757 | Sentence | denotes | Some mutants showed high RMSD in this region. |
T288 | 758-837 | Sentence | denotes | Alanine-substitution at residue N487 increased the extended loop RMSD to 2.5 Å. |
T289 | 838-931 | Sentence | denotes | Other mutations that increased the extended loop RMSD (>2 Å) include Y449A, G477A, and E484A. |
T290 | 932-1022 | Sentence | denotes | The dynamic behavior of RBD was further investigated by analyzing the RMSF of all systems. |
T291 | 1023-1098 | Sentence | denotes | As shown in Figure 4, nCOV-2019 shows less fluctuation in L3 than SARS-COV. |
T292 | 1099-1324 | Sentence | denotes | This is due to the presence of a four-residue motif (GQTQ) in nCOV-2019 L3, which forces the loop to adopt a compact structure by making two H-bonds (G485-C488 and Q474-G476) and thereby reducing the fluctuations in the loop. |
T293 | 1325-1471 | Sentence | denotes | Residues F486 and N487 play major roles in stabilizing the recognition loop by making π-stacking and H-bond interactions with residue Y83 on ACE2. |
T294 | 1472-1531 | Sentence | denotes | Alanine substitution at N487 introduced a large RMSF to L1. |
T295 | 1532-1886 | Sentence | denotes | Mutation L472 to F486 in SARS-COV was shown to favor binding by −1.2 ± 0.2 kcal/mol using FEP.26 In addition, this mutation was shown to be among the five mutations that produce a super affinity ACE2 binder based on SARS-COV RBD.6 Alanine mutations at residues Y449, G447, and E484 increased the motion in L3 characterized by a large RMSF in this region. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1038 | 1466-1470 | Gene | denotes | ACE2 | Gene:59272 |
1039 | 1727-1731 | Gene | denotes | ACE2 | Gene:59272 |
1040 | 32-36 | Species | denotes | nCOV | Tax:2697049 |
1041 | 43-51 | Species | denotes | SARS-COV | Tax:694009 |
1042 | 126-130 | Species | denotes | nCOV | Tax:2697049 |
1043 | 190-198 | Species | denotes | SARS-COV | Tax:694009 |
1044 | 278-282 | Species | denotes | nCOV | Tax:2697049 |
1045 | 350-354 | Species | denotes | nCOV | Tax:2697049 |
1046 | 565-569 | Species | denotes | nCOV | Tax:2697049 |
1047 | 645-653 | Species | denotes | SARS-COV | Tax:694009 |
1048 | 1045-1049 | Species | denotes | nCOV | Tax:2697049 |
1049 | 1089-1097 | Species | denotes | SARS-COV | Tax:694009 |
1050 | 1161-1165 | Species | denotes | nCOV | Tax:2697049 |
1051 | 1557-1565 | Species | denotes | SARS-COV | Tax:694009 |
1052 | 1748-1756 | Species | denotes | SARS-COV | Tax:694009 |
1053 | 758-765 | Chemical | denotes | Alanine | MESH:D000409 |
1054 | 790-794 | Chemical | denotes | N487 | |
1055 | 1334-1338 | Chemical | denotes | F486 | |
1056 | 1343-1347 | Chemical | denotes | N487 | |
1057 | 1459-1462 | Chemical | denotes | Y83 | |
1058 | 1472-1479 | Chemical | denotes | Alanine | MESH:D000409 |
1059 | 1763-1770 | Chemical | denotes | Alanine | MESH:D000409 |